Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You and Your Team.

Learn More →

Simultaneously Active Lesions of Vitiligo and Erythema Dyschromicum Perstans

Simultaneously Active Lesions of Vitiligo and Erythema Dyschromicum Perstans Abstract • Recently, a patient presented to us with skin that had areas of normal pigmentation, hyperpigmentation, and depigmentation. Workup eventually showed him to have simultaneously active lesions of a depigmenting disorder, vitiligo, and a hyperpigmenting disorder, erythema dyschromicum perstans. (Arch Dermatol 1988;124:1258-1260) References 1. Ramirez CO: Los Cenicientos: Problema Clinico . San Salvador, El Salvador, Central American Society of Dermatology, 1957, pp 122-130. 2. Stevenson JR, Miura M: Erythema dyschromicum perstans (ashy dermatosis) . Arch Dermatol 1966;94:196-199.Crossref 3. Knox JM, Dodge BG, Freeman RG: Erythema dyschromicum perstans . Arch Dermatol 1968;97:262-272.Crossref 4. Tschen JA, Tschen EA, McGavran MH: Erythema dyschromicum perstans . J Am Acad Dermatol 1980;2:295-302.Crossref 5. Sánchez NP, Pathak MA, Sato SS, et al: Circumscribed dermal melanoses: Classification, light, histochemical, and electron microscopic studies on three patients with the erythema dyschromicum perstans type . Int J Dermatol 1982;21:25-31.Crossref 6. Soter NA, Wand C, Freeman RG: Ultrastructural pathology of erythema dyschromicum perstans . J Invest Dermatol 1969; 52:155-162. 7. Jablonska S: Ingestion of ammonium nitrate as a possible cause of erythema dyschromicum perstans (ashy dermatosis) . Dermatologica 1975;150:287-291.Crossref 8. Mosher DB, Fitzpatrick TB, Ortonne JP, et al: Disorders of pigmentation , in Fitzpatrick TB, Eisen AZ, Wolff K, et al (eds): Dermatology in General Medicine , ed 3. New York, McGraw-Hill International Book Co, 1987, pp 794-876. 9. Grimes PE, Ghoneum M, Stockton T, et al: T-cell profiles in vitiligo . J Am Acad Dermatol 1986;14:196-201.Crossref 10. Haider RM, Walters CS, Johnson BA, et al: Aberrations in T lymphocytes and natural killer cells in vitiligo: A flow cytometric study . J Am Acad Dermatol 1986;14:733-737.Crossref 11. Naughton GK, Reggiardo D, Bystryn JC: Correlation between vitiligo antibodies and extent of depigmentation in vitiligo . J Am Acad Dermatol 1986;15:978-981.Crossref 12. Hertz KG, Gazze LA, Kirkpatrick CH, et al: Autoimmune vitiligo detection of antibodies to melanin-producing cells . N Engl J Med 1977;297:634-637.Crossref 13. Uda H, Takei M, Mishira Y: Immunopathology of vitiligo vulgaris, Sutton's leukoderma and melanoma-associated vitiligo in relation to steroid effects: The IgG and C3 deposits in the skin . J Cutan Pathol 1984;11:114-124.Crossref 14. Hatchome N, Aiba S, Kato T, et al: Possible functional impairment of Langerhans' cells in vitiliginous skin: Reduced ability to elicit dinitrochlorobenzene contact sensitivity reaction and decreased stimulatory effect in the allogeneic mixed skin cell lymphocyte culture reaction . Arch Dermatol 1987;123:51-54.Crossref http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Archives of Dermatology American Medical Association

Simultaneously Active Lesions of Vitiligo and Erythema Dyschromicum Perstans

Loading next page...
 
/lp/american-medical-association/simultaneously-active-lesions-of-vitiligo-and-erythema-dyschromicum-nsYau50grU
Publisher
American Medical Association
Copyright
Copyright © 1988 American Medical Association. All Rights Reserved.
ISSN
0003-987X
eISSN
1538-3652
DOI
10.1001/archderm.1988.01670080070022
Publisher site
See Article on Publisher Site

Abstract

Abstract • Recently, a patient presented to us with skin that had areas of normal pigmentation, hyperpigmentation, and depigmentation. Workup eventually showed him to have simultaneously active lesions of a depigmenting disorder, vitiligo, and a hyperpigmenting disorder, erythema dyschromicum perstans. (Arch Dermatol 1988;124:1258-1260) References 1. Ramirez CO: Los Cenicientos: Problema Clinico . San Salvador, El Salvador, Central American Society of Dermatology, 1957, pp 122-130. 2. Stevenson JR, Miura M: Erythema dyschromicum perstans (ashy dermatosis) . Arch Dermatol 1966;94:196-199.Crossref 3. Knox JM, Dodge BG, Freeman RG: Erythema dyschromicum perstans . Arch Dermatol 1968;97:262-272.Crossref 4. Tschen JA, Tschen EA, McGavran MH: Erythema dyschromicum perstans . J Am Acad Dermatol 1980;2:295-302.Crossref 5. Sánchez NP, Pathak MA, Sato SS, et al: Circumscribed dermal melanoses: Classification, light, histochemical, and electron microscopic studies on three patients with the erythema dyschromicum perstans type . Int J Dermatol 1982;21:25-31.Crossref 6. Soter NA, Wand C, Freeman RG: Ultrastructural pathology of erythema dyschromicum perstans . J Invest Dermatol 1969; 52:155-162. 7. Jablonska S: Ingestion of ammonium nitrate as a possible cause of erythema dyschromicum perstans (ashy dermatosis) . Dermatologica 1975;150:287-291.Crossref 8. Mosher DB, Fitzpatrick TB, Ortonne JP, et al: Disorders of pigmentation , in Fitzpatrick TB, Eisen AZ, Wolff K, et al (eds): Dermatology in General Medicine , ed 3. New York, McGraw-Hill International Book Co, 1987, pp 794-876. 9. Grimes PE, Ghoneum M, Stockton T, et al: T-cell profiles in vitiligo . J Am Acad Dermatol 1986;14:196-201.Crossref 10. Haider RM, Walters CS, Johnson BA, et al: Aberrations in T lymphocytes and natural killer cells in vitiligo: A flow cytometric study . J Am Acad Dermatol 1986;14:733-737.Crossref 11. Naughton GK, Reggiardo D, Bystryn JC: Correlation between vitiligo antibodies and extent of depigmentation in vitiligo . J Am Acad Dermatol 1986;15:978-981.Crossref 12. Hertz KG, Gazze LA, Kirkpatrick CH, et al: Autoimmune vitiligo detection of antibodies to melanin-producing cells . N Engl J Med 1977;297:634-637.Crossref 13. Uda H, Takei M, Mishira Y: Immunopathology of vitiligo vulgaris, Sutton's leukoderma and melanoma-associated vitiligo in relation to steroid effects: The IgG and C3 deposits in the skin . J Cutan Pathol 1984;11:114-124.Crossref 14. Hatchome N, Aiba S, Kato T, et al: Possible functional impairment of Langerhans' cells in vitiliginous skin: Reduced ability to elicit dinitrochlorobenzene contact sensitivity reaction and decreased stimulatory effect in the allogeneic mixed skin cell lymphocyte culture reaction . Arch Dermatol 1987;123:51-54.Crossref

Journal

Archives of DermatologyAmerican Medical Association

Published: Aug 1, 1988

References